| J0897 | Injection, denosumab, 1 mg | 40,920 | $20 | $736.6K |
| J0129 | Injection, abatacept, 10 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 12,830 | $30 | $436.1K |
| J9312 | Injection, rituximab, 10 mg | 2,200 | $60 | $138.6K |
| J3262 | Injection, tocilizumab, 1 mg | 24,650 | $10 | $123.3K |
| J0717 | Injection, certolizumab pegol, 1 mg (code may be used for medicare when drug administered under the direct supervision of a physician, not for use when drug is self administered) | 28,800 | $1 | $115.2K |
| 99214 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the… | 1,250 | $90 | $113.6K |
| J1745 | Injection, infliximab, excludes biosimilar, 10 mg | 4,090 | $30 | $106.3K |
| J1602 | Injection, golimumab, 1 mg, for intravenous use | 5,350 | $10 | $58.9K |
| 96413 | Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These… | 410 | $100 | $41.3K |
| 99213 | The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a low level of medical decision making, and/or the… | 250 | $70 | $16.4K |